The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(Jul 2023)
Editorial: Patient-derived tumor models for drug development
Hatim E. Sabaawy,
Massimo Broggini,
Shiv K. Gupta
Affiliations
Hatim E. Sabaawy
Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
Massimo Broggini
Laboratory of Molecular Pharmacology, Department of Oncology, Istituto di Ricerche farmacologiche Mario Negri (IRCCS), Milan, Italy
Shiv K. Gupta
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, United States
DOI
https://doi.org/10.3389/fonc.2023.1243534
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
patient-derived models of cancer
organoid
patient-derived xenograft (PDX)
syngeneic graft
pre-clinical drug screen for cancer
immune checkpoint inhibitors
WeChat QR code
Close